Technical Analysis for VIR - Vir Biotechnology, Inc.

Grade Last Price % Change Price Change
grade C 12.99 -0.23% -0.03
VIR closed down 0.23 percent on Friday, December 6, 2019, on 5 percent of normal volume.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical VIR trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Bearish Engulfing Bearish -0.23%
Crossed Above 20 DMA Bullish -4.49%
New Uptrend Bullish -4.49%
Pocket Pivot Bullish Swing Setup -4.49%
Outside Day Range Expansion -4.49%
20 DMA Resistance Bearish -0.61%
Doji - Bearish? Reversal -0.61%
Wide Bands Range Expansion -0.61%
20 DMA Resistance Bearish -1.59%

Older signals for VIR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis. The company has grant agreement with Bill & Melinda Gates Foundation and National Institutes of Health; option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; collaboration and license agreement Alnylam Pharmaceuticals, Inc.; collaboration, license and option agreement Visterra, Inc.; and license agreement with The Rockefeller University and MedImmune, Inc. It operates in the United States, Oregon, Massachusetts, and Switzerland. The company was founded in 2016 and is headquartered in San Francisco, California.
Biotechnology Therapeutic Products Astrazeneca Alnylam Pharmaceuticals Therapeutic Tuberculosis Pharmaceutical Companies Medimmune Rockefeller University Serious Infectious Diseases Treatment Of Hepatitis B

Is VIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 16.5
52 Week Low 11.65
Average Volume 150,438
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 12.86
10-Day Moving Average 12.68
Average True Range 0.78
ADX 22.38
+DI 18.72
-DI 16.70
Chandelier Exit (Long, 3 ATRs ) 13.79
Chandelier Exit (Short, 3 ATRs ) 13.99
Upper Bollinger Band 13.88
Lower Bollinger Band 11.84
Percent B (%b) 0.56
BandWidth 15.89
MACD Line -0.35
MACD Signal Line -0.48
MACD Histogram 0.1314
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.09
Resistance 3 (R3) 14.20 13.94 13.90
Resistance 2 (R2) 13.94 13.66 13.89 13.84
Resistance 1 (R1) 13.47 13.49 13.34 13.36 13.78
Pivot Point 13.21 13.21 13.15 13.16 13.21
Support 1 (S1) 12.74 12.93 12.61 12.63 12.20
Support 2 (S2) 12.48 12.76 12.43 12.14
Support 3 (S3) 12.01 12.48 12.08
Support 4 (S4) 11.90